StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Allergan (AGN) CEO says Valeant's (VRX) Bausch & Lomb fits profile of business targeted - CNBC
April 6, 2016 9:12 AM
Allergan (NYSE: AGN) CEO says ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Rumors
Short Sales
Trader Talk
Next Articles
Valeant (VRX) Traders Eye Key Level as Shares Retake Session Highs
April 6, 2016 2:38 PM
Piper Jaffray Sees Value in Allergen (AGN) Post-Pfizer; PT to $311
April 6, 2016 11:29 AM
Pershing Square's Ackman Says Valeant (VRX) was Passive Holding Until Recent, Board Focused on CEO Search
April 6, 2016 10:10 AM